$8.93
-0.43-4.59%
At Close: -
$8.93
00.00%
After Hours: Jul 26, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Alignment Healthcare (NASDAQ:ALHC) Stock, Analyst Ratings, Price Targets, Forecasts
Alignment Healthcare Inc has a consensus price target of $12.66 based on the ratings of 17 analysts. The high is $25 issued by Morgan Stanley on August 31, 2021. The low is $4.5 issued by Barclays on March 6, 2024. The 3 most-recent analyst ratings were released by Stifel, Baird, and Piper Sandler on July 26, 2024, May 30, 2024, and May 8, 2024, respectively. With an average price target of $10 between Stifel, Baird, and Piper Sandler, there's an implied 11.98% upside for Alignment Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Baird
Piper Sandler
Stephens & Co.
Barclays
1calculated from analyst ratings
Analyst Ratings for Alignment Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/26/2024 | Buy Now | 34.38% | Stifel | Craig Jones | $9 → $12 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 11.98% | Baird | Michael Ha | → $10 | Initiates | → Outperform | Get Alert |
| 05/08/2024 | Buy Now | -10.41% | Piper Sandler | Jessica Tassan | $6 → $8 | Upgrade | Neutral → Overweight | Get Alert |
| 05/03/2024 | Buy Now | -21.61% | Stephens & Co. | Scott Fidel | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 04/23/2024 | Buy Now | 0.78% | Stifel | Craig Jones | $11 → $9 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | -32.81% | Piper Sandler | Jessica Tassan | $12 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/06/2024 | Buy Now | -49.61% | Barclays | Andrew Mok | → $4.5 | Initiates | → Underweight | Get Alert |
| 02/28/2024 | Buy Now | -4.82% | UBS | Kevin Caliendo | $9 → $8.5 | Maintains | Neutral | Get Alert |
| 01/24/2024 | Buy Now | 23.18% | Stifel | Craig Jones | → $11 | Initiates | → Buy | Get Alert |
| 01/09/2024 | Buy Now | 34.38% | Raymond James | John Ransom | $10 → $12 | Maintains | Strong Buy | Get Alert |
| 01/09/2024 | Buy Now | 17.58% | Stephens & Co. | Scott Fidel | $10 → $10.5 | Maintains | Equal-Weight | Get Alert |
| 12/21/2023 | Buy Now | 0.78% | UBS | Kevin Caliendo | $6.5 → $9 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | -18.81% | B of A Securities | Kevin Fischbeck | → $7.25 | Downgrade | Buy → Neutral | Get Alert |
| 10/16/2023 | Buy Now | 11.98% | Raymond James | John Ransom | $9 → $10 | Upgrade | Outperform → Strong Buy | Get Alert |
| 10/12/2023 | Buy Now | 0.78% | Stephens & Co. | Scott Fidel | → $9 | Initiates | → Equal-Weight | Get Alert |
| 08/30/2023 | Buy Now | 34.38% | Morgan Stanley | Ricky Goldwasser | $19 → $12 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | 112.77% | Morgan Stanley | Ricky Goldwasser | $19 → $19 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | -32.81% | UBS | Kevin Caliendo | $8 → $6 | Maintains | Neutral | Get Alert |
| 07/07/2023 | Buy Now | 11.98% | JP Morgan | Lisa Gill | $12 → $10 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | 0.78% | Raymond James | John Ransom | → $9 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/19/2023 | Buy Now | 34.38% | Goldman Sachs | Nathan Rich | $14 → $12 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 56.77% | Goldman Sachs | Nathan Rich | $21 → $14 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 34.38% | Piper Sandler | Jessica Tassan | $19 → $12 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 11.98% | TD Cowen | Gary Taylor | $17 → $10 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | 34.38% | JP Morgan | Lisa Gill | $22 → $12 | Downgrade | Overweight → Neutral | Get Alert |
| 11/21/2022 | Buy Now | — | Raymond James | John Ransom | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/22/2022 | Buy Now | 90.37% | Cowen & Co. | Gary Taylor | $12 → $17 | Maintains | Outperform | Get Alert |
| 08/10/2022 | Buy Now | 112.77% | Morgan Stanley | Ricky Goldwasser | $18 → $19 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 90.37% | UBS | Kevin Caliendo | $11 → $17 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | 135.16% | Goldman Sachs | Nathan Rich | $14 → $21 | Maintains | Buy | Get Alert |
| 08/08/2022 | Buy Now | 135.16% | Barclays | Sarah James | $14 → $21 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 146.36% | Raymond James | John Ransom | $20 → $22 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 123.96% | Piper Sandler | Jeff Garro | $15 → $20 | Maintains | Overweight | Get Alert |
| 06/07/2022 | Buy Now | 101.57% | Morgan Stanley | Ricky Goldwasser | $21 → $18 | Maintains | Overweight | Get Alert |
| 05/26/2022 | Buy Now | 56.77% | B of A Securities | Kevin Fischbeck | $18 → $14 | Upgrade | Neutral → Buy | Get Alert |
| 05/12/2022 | Buy Now | 56.77% | Goldman Sachs | Nathan Rich | $16 → $14 | Maintains | Buy | Get Alert |
| 04/04/2022 | Buy Now | 112.77% | SVB Leerink | Whit Mayo | → $19 | Initiates | → Outperform | Get Alert |
| 03/07/2022 | Buy Now | 79.17% | Goldman Sachs | Nathan Rich | $18 → $16 | Maintains | Buy | Get Alert |
| 03/07/2022 | Buy Now | 135.16% | Morgan Stanley | Ricky Goldwasser | $25 → $21 | Maintains | Overweight | Get Alert |
| 03/04/2022 | Buy Now | 23.18% | Cowen & Co. | Gary Taylor | $24 → $11 | Maintains | Outperform | Get Alert |
| 02/24/2022 | Buy Now | 67.97% | Piper Sandler | Jeff Garro | $25 → $15 | Maintains | Overweight | Get Alert |
| 01/12/2022 | Buy Now | 123.96% | Raymond James | John Ransom | $30 → $20 | Maintains | Outperform | Get Alert |
| 12/14/2021 | Buy Now | 123.96% | Goldman Sachs | Nathan Rich | — | Initiates | → Buy | Get Alert |
| 12/03/2021 | Buy Now | 123.96% | JP Morgan | Lisa Gill | — | Initiates | → Overweight | Get Alert |
| 11/08/2021 | Buy Now | 213.55% | Barclays | Sarah James | — | Maintains | Overweight | Get Alert |
| 09/10/2021 | Buy Now | 168.76% | Cowen & Co. | Gary Taylor | — | Initiates | → Outperform | Get Alert |
| 08/31/2021 | Buy Now | 179.96% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/12/2021 | Buy Now | 235.95% | Raymond James | John Ransom | — | Maintains | Outperform | Get Alert |
| 08/12/2021 | Buy Now | 179.96% | Barclays | Sarah James | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Alignment Healthcare (ALHC) stock?
The latest price target for Alignment Healthcare (NASDAQ:ALHC) was reported by Stifel on July 26, 2024. The analyst firm set a price target for $12.00 expecting ALHC to rise to within 12 months (a possible 34.38% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alignment Healthcare (ALHC)?
The latest analyst rating for Alignment Healthcare (NASDAQ:ALHC) was provided by Stifel, and Alignment Healthcare maintained their buy rating.
When was the last upgrade for Alignment Healthcare (ALHC)?
The last upgrade for Alignment Healthcare Inc happened on May 8, 2024 when Piper Sandler raised their price target to $8. Piper Sandler previously had a neutral for Alignment Healthcare Inc.
When was the last downgrade for Alignment Healthcare (ALHC)?
The last downgrade for Alignment Healthcare Inc happened on March 6, 2024 when Piper Sandler changed their price target from $12 to $6 for Alignment Healthcare Inc.
When is the next analyst rating going to be posted or updated for Alignment Healthcare (ALHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alignment Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alignment Healthcare was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
Is the Analyst Rating Alignment Healthcare (ALHC) correct?
While ratings are subjective and will change, the latest Alignment Healthcare (ALHC) rating was a maintained with a price target of $9.00 to $12.00. The current price Alignment Healthcare (ALHC) is trading at is $8.93, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.